Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5MGH

Crystal structure of pathogenic mutants of human mitochodnrial PheRS

Summary for 5MGH
Entry DOI10.2210/pdb5mgh/pdb
DescriptorPhenylalanine--tRNA ligase, mitochondrial, PHENYLALANINE (3 entities in total)
Functional Keywordscrystal structure of pathogenic human mitochondrial phers, molecular dynamic, kinetik study, aminoacylation, ligase
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight47611.00
Authors
Kartvelishvili, E.,Tworowski, D.,Vernon, H.,Chrzanowska-Lightowlers, Z.,Moor, N.,Wang, J.,Wong, L.-J.,Safro, M. (deposition date: 2016-11-21, release date: 2017-05-03, Last modification date: 2024-05-08)
Primary citationKartvelishvili, E.,Tworowski, D.,Vernon, H.,Moor, N.,Wang, J.,Wong, L.J.,Chrzanowska-Lightowlers, Z.,Safro, M.
Kinetic and structural changes in HsmtPheRS, induced by pathogenic mutations in human FARS2.
Protein Sci., 26:1505-1516, 2017
Cited by
PubMed Abstract: Mutations in the mitochondrial aminoacyl-tRNA synthetases (mtaaRSs) can cause profound clinical presentations, and have manifested as diseases with very selective tissue specificity. To date most of the mtaaRS mutations could be phenotypically recognized, such that clinicians could identify the affected mtaaRS from the symptoms alone. Among the recently reported pathogenic variants are point mutations in FARS2 gene, encoding the human mitochondrial PheRS. Patient symptoms range from spastic paraplegia to fatal infantile Alpers encephalopathy. How clinical manifestations of these mutations relate to the changes in three-dimensional structures and kinetic characteristics remains unclear, although impaired aminoacylation has been proposed as possible etiology of diseases. Here, we report four crystal structures of HsmtPheRS mutants, and extensive MD simulations for wild-type and nine mutants to reveal the structural changes on dynamic trajectories of HsmtPheRS. Using steady-state kinetic measurements of phenylalanine activation and tRNA aminoacylation, we gained insight into the structural and kinetic effects of mitochondrial disease-related mutations in FARS2 gene.
PubMed: 28419689
DOI: 10.1002/pro.3176
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.87 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon